Biocoat
Chemicals & Related Products · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
123 Rock Rd, Horsham, Pennsylvania, 1904...Phone Number
(215) 734-0888Website
www.biocoat.comRevenue
$33.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
2
1
1
1
1
About Biocoat
Biocoat Incorporated specializes in hydrophilic coatings and coating services primarily for medical devices. With over 30 years of experience, the company offers solutions including thermal and UV coatings, custom polymer synthesis, and contract coating services. Biocoat serves various medical markets, including neurovascular, cardiovascular, and gastroenterology, providing tailored coatings to enhance device performance. Their commitment to quality and innovation positions them as a leader in the hydrophilic coatings industry.Explore more
Biocoat Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biocoat your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Biocoat launches new products
Biocoat, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Biocoat has new funding data
Click to see if Biocoat had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Biocoat has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Biocoat recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Biocoat
Check out if Biocoat is spiking on competitors!
Recommended Actions
Find VP level buyers at Biocoat
Find 2 more new buyers
Compare Similar Companies to Biocoat
Compare insights from companies similar to Biocoat, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biocoat is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biocoat is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biocoat.
Biocoat Tech Stack
A closer look at the technologies used by Biocoat
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Facilities Relocation / Expansion
Biocoat is planning to move offices in January 2027. The move will impact approximately 40 employees at the existing office located at 211 Witmer Road, Horsham, PA.
Facilities Relocation/Expansion
Award
Award, Employee Engagement, Employee Relations, Employee Retention, Workforce Management, Company Culture & Policy, Diversity & Inclusion, HR Operations, Manufacturing Operations, Operations, Organizational Development, Talent Management
Project
Product Management, Intellectual Property, Legal Affairs, Healthcare Technology
Event
Events, Clinical Systems, Healthcare Technology, Manufacturing Operations, Operations
Biocoat News & Media
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today provided the following statement in response to the U.S. Federal Trade Commission’s (“FTC” or the “Agency”) announcement that it will challenge the proposed acquisition of Surmodics (the “Merger”) by funds affiliated with GTCR LLC (“GTCR”), which have an equity investment in Biocoat Inc., a maker of medical coatings: “SurmodicsMedeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area's Premier Catheter Solutions Provider
SAN JOSE, Calif., Nov. 6, 2024 /PRNewswire/ -- Medeologix, a leading brand in medical device manufacturing, today announced a significant expansion of its end-to-end catheter solutions with the addition of hydrophilic coating services, further cementing its status as the Bay Area's premier choice for advanced catheter solutions. This expansion is bolstered by a partnership with Biocoat, an industry-leading hydrophilic coating materials provider with established FDA master files to streamline regBiocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter Coating
HORSHAM, Pa., Aug. 27, 2024 /PRNewswire/ -- Biocoat Incorporated, a leader in the development, manufacturing, and application of hydrophilic coatings for medical devices, is proud to announce the issuance of a patent for "Lumen Coating Method and Apparatus." This new patent covers a...Scott D'Amour Named as Chief Financial Officer of Biocoat, Replaces the Retiring Steve Bell
HORSHAM, Pa., Nov. 14, 2023 /PRNewswire/ -- Biocoat Incorporated, a specialty manufacturer of hydrophilic biomaterial coatings and coating equipment for medical devices, announced the addition of Scott D'Amour as the new Chief Financial Officer. Mr. D'Amour is replacing Steve Bell who has...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biocoat
Sign Up For FreeTo access detailed company insights
Biocoat Incorporated specializes in hydrophilic coatings and coating services primarily for medical devices. With over 30 years of experience, the company offers solutions including thermal and UV coatings, custom polymer synthesis, and contract coating services. Biocoat serves various medical markets, including neurovascular, cardiovascular, and g... Read More
